Article Text

Download PDFPDF
EV160/#910  The impact of the covid-19 pandemic on endometrial cancer stage in a tertiary gynaecological oncology centre
  1. Teresa Treacy1,
  2. Aidin Roberts1,
  3. Edward Corry1,
  4. Claire Thompson1,
  5. Ruaidhri Mcvey1,
  6. Sarah Belton2 and
  7. Donal Brennan1
  1. 1Mater Misericordiae University Hospital, Gynaecological Oncology Department, Dublin, Ireland
  2. 2St. Vincent’s University Hospital, Gynaecology Oncology Cns In Survivorship, Dublin, Ireland

Abstract

Introduction The University College Dublin Gynecological Oncology Group (UCD-GOG), is a tertiary referral centre for gynecological cancers. A review of all cases of endometrial cancer (EC) presenting to this service from 2019 – 2022 was completed. The aim was to assess the impact of COVID-19 restrictions in March 2020 to the patterns of presentation of EC.

Methods We completed a retrospective cohort review of all cases of EC diagnosed in the UCD-GOG from 2019 – 2022 inclusive.

Results 732 patients were diagnosed with EC during this period. The histological diagnoses of 81.3% of ECs were Endometrioid Carcinoma. We observed an increase in the numbers of EC diagnoses from 177 in 2019 – 189 in 2022. We noted a year on year increase in stage 1A EC diagnoses, and an increase in the proportion of Stage 2 EC diagnoses. The incidence of all stage 3 and 4A ECs was stable over the course of time evaluated; however, we did note a 4.3% reduction in the proportion of Stage 4B EC diagnoses, falling from 8.5% to 4.2%.

Conclusion/Implications We observed an increase in the numbers of EC diagnosed from 2019 – 2022; this is consistent with the rising incidence of EC worldwide. Early-stage disease accounts for the majority of new cases diagnosed in our centre; We did not observe a significant increase in late-stage diagnoses over the course of the COVID pandemic in our centre; this reflects a service which continued to provide appropriate and timely care to those referred.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.